Updated clinical practice guidelines on the use of vaccines to prevent seasonal COVID-19, influenza, and respiratory ...

There seems to be a strong exposure-response relationship between nerandomilast and the preservation of FVC in patients with PPF and IPF.

What happens inside the lungs before COVID-19 symptoms appear? Research in mink offers a rare window into the early stages of ...

NTU Singapore is working with China's Southern University of Science and Technology (SUSTech) and Swedish biotechnology ...

Adam Feuerstein, a senior writer and biotech columnist, is the author of Adam’s Biotech Scorecard, a subscriber-only newsletter about the crossroads of drug development, business, Wall Street, and ...

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, Inc. (Nasdaq: BIAF; BIAFW), a biotechnology company advancing noninvasive diagnostics for lung cancer and other lung diseases, today released a ...

FDA expansion of the Arexvy vaccine provides protection against RSV-related lower respiratory tract disease for at-risk adults aged 18 to 49 years. The Food and Drug Administration (FDA) has expanded ...

César Manuel González, 37, used to work with stone that was engineered to endure: dense, polished slabs designed to outlast the kitchens in which they were installed. Engineered quartz countertops ...

New research linked severe bouts of COVID-19 or influenza to a 24 percent increased risk of lung cancer. Learn what steps could reduce your risk. New research has linked severe COVID-19 and flu with a ...

New research from UVA Health finds severe COVID-19 and influenza can prime the lungs for cancer and speed the disease’s development, but vaccination can help prevent those effects. “A bad case of ...

University of Virginia School of Medicine researcher Jie Sun, PhD, and colleagues found that serious viral infections “reprogram” immune cells in the lungs to facilitate the growth of cancer tumors ...

Shares fall 80% after trial results CEO sees potential in combined study data for FDA consideration Gossamer to meet the agency, pauses another study enrollment Feb 23 (Reuters) - Gossamer Bio's (GOSS ...